Zlatko Sisic

655 total citations
18 papers, 445 citations indexed

About

Zlatko Sisic is a scholar working on Physiology, Genetics and Rheumatology. According to data from OpenAlex, Zlatko Sisic has authored 18 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Genetics and 5 papers in Rheumatology. Recurrent topics in Zlatko Sisic's work include Lysosomal Storage Disorders Research (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). Zlatko Sisic is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). Zlatko Sisic collaborates with scholars based in United Kingdom, United States and Germany. Zlatko Sisic's co-authors include Emel Aygören‐Pürsün, Henrik Balle Boysen, E. Hautamaki, Kathleen Beusterien, Anette Bygum, Teresa Caballero, Suzanne Wait, Paul Harmatz, Christian J. Hendriksz and Christina Lampe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Therapeutics.

In The Last Decade

Zlatko Sisic

14 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zlatko Sisic United Kingdom 9 339 158 118 90 83 18 445
Michael Manning United States 12 326 1.0× 131 0.8× 100 0.8× 98 1.1× 77 0.9× 44 436
Nóra Veszeli Hungary 14 355 1.0× 141 0.9× 107 0.9× 147 1.6× 85 1.0× 35 466
W.H. Yang United States 8 190 0.6× 74 0.5× 51 0.4× 67 0.7× 79 1.0× 19 641
Adriane Peveling‐Oberhag Germany 7 166 0.5× 256 1.6× 136 1.2× 19 0.2× 5 0.1× 15 372
Luz Agana United States 8 51 0.2× 104 0.7× 138 1.2× 11 0.1× 37 0.4× 8 393
R. Jiji United States 9 98 0.3× 40 0.3× 21 0.2× 146 1.6× 23 0.3× 14 320
Sara Mach‐Pascual Switzerland 9 161 0.5× 49 0.3× 29 0.2× 218 2.4× 4 0.0× 12 362
Ciro Manzo Italy 10 81 0.2× 126 0.8× 137 1.2× 40 0.4× 2 0.0× 26 280
Szabolcs Benedek Hungary 8 69 0.2× 30 0.2× 47 0.4× 33 0.4× 12 0.1× 22 211
Sophie Huybrechts Belgium 12 286 0.8× 31 0.2× 18 0.2× 235 2.6× 9 0.1× 31 515

Countries citing papers authored by Zlatko Sisic

Since Specialization
Citations

This map shows the geographic impact of Zlatko Sisic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zlatko Sisic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zlatko Sisic more than expected).

Fields of papers citing papers by Zlatko Sisic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zlatko Sisic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zlatko Sisic. The network helps show where Zlatko Sisic may publish in the future.

Co-authorship network of co-authors of Zlatko Sisic

This figure shows the co-authorship network connecting the top 25 collaborators of Zlatko Sisic. A scholar is included among the top collaborators of Zlatko Sisic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zlatko Sisic. Zlatko Sisic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mole, Sara, Paul Gissen, Suzanne Wait, et al.. (2025). Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom. Orphanet Journal of Rare Diseases. 20(1). 223–223.
2.
Specchio, Nicola, Paul Gissen, Emily de los Reyes, et al.. (2024). Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data. PLoS ONE. 19(5). e0302382–e0302382. 2 indexed citations
3.
Lo, Siu Hing, Andrew Lloyd, Shuayb Elkhalifa, Zlatko Sisic, & Floortje van Nooten. (2021). Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States. PharmacoEconomics - Open. 6(2). 231–239. 2 indexed citations
4.
Lo, Siu Hing, Andrew Lloyd, Shuayb Elkhalifa, Zlatko Sisic, & Floortje van Nooten. (2021). PSY17 Time Trade-Off Utilities for Hereditary Angioedema Health States. Value in Health. 24. S232–S232.
5.
Gissen, Paul, Nicola Specchio, Andrew Olaye, et al.. (2021). Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2). Orphanet Journal of Rare Diseases. 16(1). 217–217. 10 indexed citations
6.
Lampe, Christina, Paul Harmatz, Rossella Parini, et al.. (2019). Enzyme replacement therapy initiated in adulthood: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program. Molecular Genetics and Metabolism. 127(4). 355–360. 8 indexed citations
7.
Harmatz, Paul, Christina Lampe, Rossella Parini, et al.. (2019). Enzyme replacement therapy in patients with mucopolysaccharidosis type VI: Updated findings from the MPS VI clinical surveillance program. Molecular Genetics and Metabolism. 126(2). S68–S68.
8.
Harmatz, Paul, Christina Lampe, Rossella Parini, et al.. (2019). Enzyme replacement therapy outcomes across the disease spectrum: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program. Journal of Inherited Metabolic Disease. 42(3). 519–526. 8 indexed citations
9.
Harmatz, Paul, Christina Lampe, Rossella Parini, et al.. (2018). Mucopolysaccharidosis type VI enzyme replacement therapy initiated in adulthood: Findings from the MPS VI clinical surveillance program. Molecular Genetics and Metabolism. 123(2). S59–S59.
10.
Haroldsen, Peter E., et al.. (2017). Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function. Clinical Therapeutics. 39(7). 1360–1370. 7 indexed citations
11.
Aygören‐Pürsün, Emel, Anette Bygum, Kathleen Beusterien, et al.. (2016). Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema. Patient Preference and Adherence. Volume 10. 1699–1707. 38 indexed citations
12.
Solanki, Guirish A., Peter P. Sun, Kenneth W. Martin, et al.. (2016). Cervical cord compression in mucopolysaccharidosis VI (MPS VI): Findings from the MPS VI Clinical Surveillance Program (CSP). Molecular Genetics and Metabolism. 118(4). 310–318. 28 indexed citations
13.
Stewart, Fiona, Andrew Bentley, Barbara K. Burton, et al.. (2016). Pregnancy in patients with mucopolysaccharidosis: a case series. Molecular Genetics and Metabolism Reports. 8. 111–115. 10 indexed citations
14.
Harmatz, Paul, Eugen Mengel, Tarekegn Geberhiwot, et al.. (2016). Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study. American Journal of Medical Genetics Part A. 173(2). 375–383. 22 indexed citations
15.
Stewart, Fiona, Andrew Bentley, Barbara K. Burton, et al.. (2016). Expert Opinions on Managing Fertility and Pregnancy in Patients With Mucopolysaccharidosis. SHILAP Revista de lepidopterología. 4. 4078079097–4078079097. 1 indexed citations
16.
Bygum, Anette, Emel Aygören‐Pürsün, Kathleen Beusterien, et al.. (2015). Burden of Illness in Hereditary Angioedema: A Conceptual Model. Acta Dermato Venereologica. 95(6). 706–710. 75 indexed citations
17.
Aygören‐Pürsün, Emel, Anette Bygum, Kathleen Beusterien, et al.. (2014). Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet Journal of Rare Diseases. 9(1). 99–99. 97 indexed citations
18.
Caballero, Teresa, Emel Aygören‐Pürsün, Anette Bygum, et al.. (2013). The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe. Allergy and Asthma Proceedings. 35(1). 47–53. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Manning Breakdown of academic impact, for papers by Nóra Veszeli Breakdown of academic impact, for papers by W.H. Yang Breakdown of academic impact, for papers by Adriane Peveling‐Oberhag Breakdown of academic impact, for papers by Luz Agana Breakdown of academic impact, for papers by R. Jiji Breakdown of academic impact, for papers by Sara Mach‐Pascual Breakdown of academic impact, for papers by Ciro Manzo Breakdown of academic impact, for papers by Szabolcs Benedek Breakdown of academic impact, for papers by Sophie Huybrechts
Rankless by CCL
2026